Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 8/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.41 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.41 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.41 |
| ▸ | GABBR2 | O75899 | 3/20 | 0.39 |
| ▸ | GABBR1 | Q9UBS5 | 3/20 | 0.39 |
| ▸ | BLM | P54132 | 2/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | THPO | P40225 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8147759 | 0.86 | FDPS (0.47) | FDPSLMNAPDE3AADRB3PDE4D | |
| SCHEMBL8619867 | 0.81 | GABBR2 (0.33) | FDPSLMNAPDE3AADRB3PDE4D | |
| SCHEMBL9243663 | 0.74 | FDPS (0.41) | FDPSLMNAPDE3AADRB3PDE4D | |
| SCHEMBL5493028 | 0.67 | FDPS (0.45) | FDPSLMNAPDE3AADRB3PDE4D | |
| SCHEMBL5054818 | 0.65 | ANPEP (0.44) | FDPSLMNAPDE3AADRB3PDE4D | |
| SCHEMBL8618015 | 0.64 | LMNA (0.35) | FDPSLMNA | |
| SCHEMBL6665925 | 0.61 | FDPS (0.50) | FDPS | |
| SCHEMBL5059579 | 0.61 | FDPS (0.55) | FDPSLMNAGABBR2GABBR1BLM | |
| SCHEMBL5054803 | 0.61 | FDPS (0.41) | FDPSLMNAPDE3AADRB3PDE4D | |
| Ethylenediamine SCHEMBL3636616 | 0.59 | FDPS (0.50) | FDPSLMNAPDE3AADRB3PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040170595-A1 | Multi-arm block copolymers as drug delivery vehicles | NEKTAR THERAPEUTICS AL, CORPORATION | 2004-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040170595-A1 | Multi-arm block copolymers as drug delivery vehicles | BCR, ABCB1, CHMP4B | FDPS 2773/4885LMNA 1161/4885PDE3A 4605/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.